Skip to main content
Back to Khosla Ventures

Khosla Ventures's Pharmaceutical Portfolio

Browse 9 Pharmaceutical companies funded by Khosla Ventures. See funding amounts, founder contacts, and investment details.

Pharmaceutical Companies
9
Total Funding in Pharmaceutical
$335.4M

Pharmaceutical Portfolio Companies (9)

Export
BiotechnologyLife ScienceMachine LearningPharmaceutical

Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets.

Lexington, United States
June 2022
$30.0M
Series A

Founder Contacts

30,000+ verified contacts

Health CareMedicalMobilePharmaceutical

Nimble provides a pharmacy experience centered around the patient's needs to provide a more streamlined workflow.

Redwood City, United States
June 2022
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyChemicalHealth CareLife ScienceMachine LearningPharmaceuticalQuantum ComputingTherapeutics

Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.

Palo Alto, United States
May 2023
Seed

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareMachine LearningMedicalPharmaceutical

Numerion Labs develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery.

San Francisco, United States
March 2026
$19.8M
Series D

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareMachine LearningMedicalPharmaceutical

Atomwise develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery.

San Francisco, United States
January 2024
$45.0M
Series C

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CareLife ScienceMachine LearningPharmaceutical

GEn1E is a clinical-stage multi-target AI platform. They develop novel, next-gen, immunomodulators for rare & inflammatory diseases.

Palo Alto, United States
December 2025
$5.5M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyLife SciencePharmaceuticalTherapeutics

BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.

Richmond, United States
January 2026
$115.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMachine LearningPharmaceuticalTherapeutics

Arpeggio builds technology to watch and learn how drugs work.

Boulder, United States
November 2025
$20.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyPetPharmaceuticalVeterinary

Loyal is a clinical-stage veterinary medicine company dedicated to extending the healthy lifespan of senior dogs.

San Francisco, United States
February 2026
$100.0M
Series C

Founder Contacts

30,000+ verified contacts

Explore Khosla Ventures's Full Portfolio

View all companies funded by Khosla Ventures across every industry and funding stage.

View Full Khosla Ventures Portfolio